•“c‰xŽjF•Ž่EˆใŠw”ŽŽm

Œค‹†•ช–์F Šด๕–hŒไ–ฦ‰uCTh1/Th2ƒoƒ‰ƒ“ƒXCƒTƒCƒgƒJƒCƒ“CƒPƒ‚ƒJƒCƒ“CRŒด’๑Žฆื–E

Œค‹†‹ฦัF

1) Mise-Omata, S., Kuroda, E., Niikura, J., Yamashita, U., Obata, Y. and Doi, T.S.: the proximal kB site in IL-23p19 promoter is responsible for the trans eruption dependent on RelA and c-Rel. J. Immunology, in press, 2007.

2) Nakano, Y., Kuroda, E., Kito, T., Uematsu, S., Akira, S., Yokota, A., Nishizawa, S. and Yamashita, U.: Glioma-deriued soluble factors induce prostaglandin E2 synthesis and mPGES-I expression in murine microglia, J. Neurosurgery, in press, 2007.

3) Kuroda, E., Noguchi, J., Doi, T., Uematsu, S., Akira, S. and Yamashita, U.: IL-3 is an important differentiation facter for the development of prostaglandin E2-producing macrophages between@C57BL/6@and@BALB/c nice. Eur. J. Immunology 37: 2185-2195, 2007.

4) Horita, H., Kuroda, E., Hachisuga, T., Kashimura, M. and Yamashita, U.: Induction of prostaglandin E2 production by leukemia inhibitory factor promotes migration of first trimester extravillous trophoblast cell line, HTR-8/SVneo. Human Reproduction, 22:1081-1089, 2007.

5) Nakano. Y., Kuroda, E., Kito. T., Yokota, A. and Yamashita, U.: Induction of macrophagic prostaglandin E2 synthesis by glioma cells. J. Neurosurgery, 104:574-582,2006.

6) Kuroda, E., Noguchi, J., Doi, T., Yoshida, Y., Mise-Omata, S. and Yamashita, U.: Strain difference in murine macrophage functions : Prostaglandins as amarher proceedings of the International Symposium on Low-Dose Radiation Exposure and Bio-Defeuse system. P.37-39,2006.

7) Noguchi, J., Kuroda, E. and Yamashita, U.: Strain difference of murine bone marrow-derived mast cell functions. J. Leuk. Biol. 78: 605-611, 2005.

8) Okada, K., Kuroda, E., Yoshida, Y., Yamashita, U., Suzumura, O. and Tsuji, S.: Effects of interferon-b on the cytokine production of astrocytes. J. Neuroimmunol., 159 : 48-54, 2005.

9) Yamashita, U., Sugiura, T., Yoshida, Y. and Kuroda, E.: Effect of endocrine disrupters on macrophage function in vivo. J.UOEH, 27: 1-10, 2005.

10) Sugiura, T., Kuroda, E. and Yamashita, U.: Dysfunction of macrophages in metallothionein-knock out mice. J.UOEH, 26: 193-205. 2004.

11) Yamashita, U., Kuroda, E., Yoshida, Y. and Sugiura, T.: Effect of endocrine disrupters on immune responses in vivo. J. UOEH, 25: 365-374, 2003.

12) Kuroda, E. and Yamashita, U.: Assay system for the effect of prostaglandin E2 in the determination of polarized cytokine production. Methods in Molecular Biology, Vol. 249, Cytokine Protocols, 229-238, 2003.

13) Kuroda, E. and Yamashita, U.: Mechanisms of enhanced macrophage-mediated prostaglandin E2 production and its suppressive role for Th1 activation in Th2-dominan BALB/c mice. J. Immunol., 170 : 757-764, 2003.

14) Kito, T., Kuroda, E. Yokota, A. and Yamashita, U.: Cytotoxicity in glioma cells due to interleukin-12 and interleukin-18-stimulated macrophages mediated by interferon-g-regulated nitric oxide. J. Neurosurg., 98 : 385-399, 2003.

15) Yamashita, U., Sugiura, T., Yoshida, Y. and Kuroda, E.: Effect of endocrine disrupters on thymocytes in vitro. J.UOEH, 25: 161-170, 2003.

16) Yamashita, U. and Kuroda, E.: Regulation of macrophage-derived chemokine (MDC; CCL22) production. Critical Rev. Immunol., 22 : 105-114, 2002.

17) Kuroda, E., Kito, T. and Yamashita, U.: Reduced expression of STAT4 and IFN-g in macrophages from BALB/c mice. J. Immunol., 168 : 5477-5482, 2002.

18) Kito, T., Kuroda, E., Yokota, A. and Yamashita, U.: Enhancement of macrophage cytotoxicity against murine gliomas by interferon b: increase in nitric oxide production in responses to glioma-derived soluble factors. J. Neurosurg., 97 : 619-626, 2002.

19) Yamada, H., Kuroda, E., Matsumoto, S., Matsumoto, T., Yamada, T. and Yamashita, U.: Prostaglandin E2 down-regulates viable Bacille de Calmette et Guerin-induced bladder cancer cell, MBT-2 in vitro. Clin. Exp. Immunol., 128 : 52-58, 2002

20) Kuroda, E., Yoshida, Y., Shan, B.E. and Yamashita, U.: Suppression of macrophage interleukin-12 and tumor necrosis factor-a prodution in mice infected with Toxocara canis. Parasite Immunol., 23 : 305-311, 2001.


21) Kuroda, E., Sugiura, T., Okada, K., Zeki, K. and Yamashita, U.: Prostaglandin E2 up-regulates macrophage-derived chemokine (MDC) production, but suppresses interferon-inducible protein-10 (IP-10) production by antigen-presenting cells. J. Immunol., 166 : 1650-1658, 2001.

22) Yoshida, Y., Myozaki, M., Kuroda E. and Yamashita, U. : Cytotoxic effect of an anti-liver monoclonal autoantibody obtained after neonatal thymectomy in mice. J. Autoimmunity, 16: 373-382, 2001.

23) Kishi, H., Kuroda, E., Mishima, H. K. and Yamashita, U.: Role of TGF-b in the retinoic acid-induced inhibition of proliferation and melanin synthesis in chick retinal pigment epithelial cells in vitro. Cell Biol. Int., 25: 1125-1129, 2001.

24) Okada, K., Sugiura, T., Kuroda, E., Tsuji, S. and Yamashita, U.: Phenytoin promotes Th2 type immune response in mice. Clin. Exp. Immunol., 124 : 406-413, 2001.

25) Kuroda, E., Sugiura, T., Zeki, K., Yoshida, Y. and Yamashita, U.: Sensitivity difference to the suppressive effect of prostaglandin E2 among mouse strains : A possible mechanism to polarize Th2 type response in BALB/c mice. J. Immunol., 164 : 2386-2395, 2000.

26) Kawakami, Y., Nagai, N., Ohama, K., Zeki, K., Yoshida, Y., Kuroda, E. and Yamashita, U.: Macrophage-colony stimulating factor inhibits growth of human ovarian cancer cells in vitro. Eur. J. Cancer, 36 : 1991-1997, 2000.


Šw‰๏Šˆ“ฎF“๚–{–ฦ‰uŠw‰๏‰๏ˆ๕C“๚–{Š๑ถ’ŽŠw‰๏‰๏ˆ๕


---------------------------------------------------------------------------------------------------------


•ถำFˆใŠw•”–ฦ‰uŠw‹ณŽบi‹g“cˆภGj

XV“๚F•ฝฌ21”N4ŒŽ8“๚